Our president and board members talk to the Skoll World Forum about the art and science of innovation
What happens when you invite top global health leaders to share their insights? As it turns out, candid discussion on the world’s most pressing health challenges—and the transformative innovations that can solve them—is only the beginning.
In its State of Global Health series, the Skoll World Forum catches up with leaders working across sectors and countries to save lives. This month, our president and CEO and three of our board members offer their thoughts on the art and science of innovation, the power of public-private partnerships, and their willingness to look complexity in the eye—good news for children, families, and communities worldwide.
Prior experience in the global arena helps, says Steve Davis of his first year as president and CEO of PATH—but a natural willingness to push boundaries in the quest for smart solutions doesn’t hurt, either. Markets, funding priorities, and even the diseases people face are changing, but there are also more sources of innovation than ever: “Ideas no longer travel just from west to east or north to south,” says Davis. Innovation today is “moving in all directions and coming from all places,” but PATH’s work reflects this complexity. “We’ve been disrupting traditional thinking and approaches—drawing outside the lines, you could say—since the 1970s. It’s in our DNA.” Read more on the Skoll World Forum >>
The region with the fastest-growing HIV/AIDS epidemic may not be the one you’d expect. George Gotsadze reveals the answer and opens fresh discussion on the best investments to improve lives; strengths (and challenges) for key global players; and the role of nongovernmental organizations (NGOs) in future efforts. “[NGOs] like PATH, which are advocates for those marginalized by society, are pivotal in attracting governments’ and society’s attention to issues that are important for tackling the health problems of our nations. . . . Partnering with governments and communities is part of what PATH has done—and done well—for 35 years.” Read more on the Skoll World Forum >>
For Africa, it’s “now or never” says Alex Chika Ezeh. “I believe Africa is standing on the precipice where the actions we take today will determine whether Africa will join the rest of the world in achieving significant improvements in human well-being or be perpetually left behind by the rest of humanity.” Ezeh explains top public health trends in Africa, examines how persistent inequalities undermine health, and opens up new insights into how Africans—and the global community—can begin to solve these dilemmas. Read more on the Skoll World Forum >>
Kevin Reilly, a long-time pharmaceutical and vaccine industry leader, is no stranger to complexity: “Getting a vaccine successfully from the factory door to the arms of millions of children in low-resource settings—that’s an enormously complicated task.” Both the work of developing and of delivering vaccines is immensely challenging (and different), he explains, but increased understanding between pharmaceutical and vaccine manufacturers and global health organizations, along with patience and persistence, are accelerating efforts and saving lives. Read more on the Skoll World Forum >>